Nephrotoxicity associated with intravenous colistin

Clinical Infectious Diseases

Volumn 49, Issue 11, 2009, Pages 1773-

  Tarchini, Giorgio ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLISTIN; POLYMYXIN B;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; COMORBIDITY; DRUG EFFECT; GERIATRIC PATIENT; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COLISTIN; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; MALE; UNITED STATES; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 72849139079     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648116     Document Type: Letter

References (3)

1. Hartzell JD, Neff R, Ake J, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009; 48:1724-1728
2. Falagas ME, Rafailidis PI. Nephrotoxicity of colistin: new insight into an old antibiotic. Clin Infect Dis 2009; 48:1729-1731
3. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52:2014-2018